Myelodysplastic syndromes — VA Rating Criteria (38 CFR DC 7725)
The VA rates Myelodysplastic syndromes under 38 CFR 38 CFR § 4.117, Diagnostic Code 7725, from 30% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy. Related conditions in the Hematologic body system share this rating framework.
What are the VA rating criteria for Myelodysplastic syndromes?
Requiring at least 1 but no more than 3 blood or platelet transfusions per 12-month period; infections requiring hospitalization at least 1 but no more than 2 times per 12-month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent (ESA) for 12 weeks or less per 12-month period
Requiring 4 or more blood or platelet transfusions per 12-month period; or infections requiring hospitalization 3 or more times per 12-month period
Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy
“Requiring 4 or more blood or platelet transfusions per 12-month period; or infections requiring hospitalization 3 or more times per 12-month period”
How does the VA rate Hematologic conditions?
Common Questions About Myelodysplastic syndromes VA Ratings
What is the VA disability rating for Myelodysplastic syndromes?
The VA rates Myelodysplastic syndromes under Diagnostic Code 7725 at the following tiers: 30%, 60%, 100%. The minimum 30% rating requires: Requiring at least 1 but no more than 3 blood or platelet transfusions per 12-month period; infections requiring hospitalization at least 1 but no more than 2 times per 12-month period; or requiring biologic therapy on an ongoing basis or erythropoiesis stimulating agent (ESA) for 12 weeks or less per 12-month period. The maximum 100% rating requires: Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy.
What is Diagnostic Code 7725?
Diagnostic Code 7725 is the VA rating identifier for Myelodysplastic syndromes within 38 CFR 38 CFR § 4.117. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for Myelodysplastic syndromes?
The highest schedular rating for Myelodysplastic syndromes under DC 7725 is 100%. This tier requires: Requiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy. Veterans who cannot secure substantially gainful employment due to Myelodysplastic syndromes alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.
What 38 CFR section governs Myelodysplastic syndromes ratings?
Myelodysplastic syndromes is rated under 38 CFR 38 CFR § 4.117, Diagnostic Code 7725. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to Myelodysplastic syndromes?
Secondary conditions caused or aggravated by Myelodysplastic syndromes may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for Myelodysplastic syndromes?
Service connection for Myelodysplastic syndromes requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits